# The Vietnam Chloroquine Treatment on COVID-19

> **NCT04328493** · PHASE2 · COMPLETED · sponsor: **Oxford University Clinical Research Unit, Vietnam** · enrollment: 10 (actual)

## Conditions studied

- SARS-CoV-2 Infection
- COVID-19

## Interventions

- **DRUG:** Chloroquine phosphate

## Key facts

- **NCT ID:** NCT04328493
- **Lead sponsor:** Oxford University Clinical Research Unit, Vietnam
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-07
- **Primary completion:** 2020-09-10
- **Final completion:** 2020-09-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-05-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04328493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04328493, "The Vietnam Chloroquine Treatment on COVID-19". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04328493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*